Cargando…

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer

Ovarian cancer (OC) is the most lethal cancer of all gynecological malignancies, while endometrial cancer (EC) is the most common one. Current strategies for OC/EC diagnosis consist of the extraction of a solid tissue from the affected area. This sample enables the study of specific biomarkers and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qian, Zhang, Zi-Han, Wang, Shu, Lang, Jing-He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938177/ https://www.ncbi.nlm.nih.gov/pubmed/31920340 http://dx.doi.org/10.2147/OTT.S227156

Ejemplares similares

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Circulating cell-free DNA content as blood based biomarker in endometrial cancer
por: Cicchillitti, Lucia, et al.
Publicado: (2017)

Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015)

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer
por: Feng, Weiwei, et al.
Publicado: (2021)

Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study
por: Jiang, Xuan, et al.
Publicado: (2020)

The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA
por: Henriksen, Tenna V., et al.
Publicado: (2020)

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
por: Moss, Esther L., et al.
Publicado: (2020)

Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer
por: Grassi, Tommaso, et al.
Publicado: (2021)

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
por: Openshaw, Mark R., et al.
Publicado: (2015)

The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
por: Riethdorf, Sabine, et al.
Publicado: (2017)

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
por: Widschwendter, Martin, et al.
Publicado: (2017)

Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Zhou, Quan, et al.
Publicado: (2016)

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
por: Harris, Faye R., et al.
Publicado: (2016)

Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
por: Yang, Fang, et al.
Publicado: (2021)

Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer
por: Ronchetti, Livia, et al.
Publicado: (2022)

Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis
por: Gunderson, Camille C, et al.
Publicado: (2022)

Clinical correlates of circulating cell-free DNA tumor fraction
por: Bredno, Joerg, et al.
Publicado: (2021)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management
por: Hassan, Sadia, et al.
Publicado: (2022)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
por: Huang, Chiang-Ching, et al.
Publicado: (2019)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

Circulating Tumor DNA in Pediatric Cancer
por: Doculara, Louise, et al.
Publicado: (2022)

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors
por: Kujala, Jouni, et al.
Publicado: (2022)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer
por: Jie, Xiaoxiang, et al.
Publicado: (2022)

Correction: Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer
por: Ronchetti, Livia, et al.
Publicado: (2023)

Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
por: Han, Mi-Ryung, et al.
Publicado: (2020)

The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Lu, Yuanyuan, et al.
Publicado: (2021)

The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
por: Shoukry, Mira, et al.
Publicado: (2021)

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
por: de Abreu, Ana Regina, et al.
Publicado: (2023)

Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
por: Vlataki, Katerina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jj77qticlofeomi4nkl6k6vcov